Vir Biotechnology’s CAO, Brent Sabatini, sold 1,530 shares of the company’s stock on February 13th at an average price of $7.79, reducing his stake by 3.10%. Following the sale, he directly owns 47,872 shares valued at approximately $372,923. The stock traded up 4.2% to $7.82 midday, with a mixed but predominantly positive analyst outlook and an average target price of $16.29.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Vir Biotechnology (NASDAQ:VIR) CAO Brent Sabatini Sells 1,530 Shares
Vir Biotechnology’s CAO, Brent Sabatini, sold 1,530 shares of the company’s stock on February 13th at an average price of $7.79, reducing his stake by 3.10%. Following the sale, he directly owns 47,872 shares valued at approximately $372,923. The stock traded up 4.2% to $7.82 midday, with a mixed but predominantly positive analyst outlook and an average target price of $16.29.